Clinical Trial Update: Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial compares preoperative FOLFOX chemotherapy to postoperative risk-adapted chemotherapy in patients with locally advanced rectal cancer and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Ralf Hofheinz | Conditions: Rectal Cancer | Phase 3 | Status: RECRUITING